Mark Mortenson Buys 45,000 Shares of CLNN

CLNN's Chief Science Officer acquired 45,000 shares, reflecting insider confidence.

Written by EarningsIQ · Published Jun 15, 2026, 3:01 PM EDT · Updated Jun 15, 2026, 4:01 PM EDT

Key Points

Mark Mortenson, Chief Science Officer of CLNN, bought 45,000 shares on June 11, 2026, at no cost per share.
CLNN shares traded at around $5.78, with several institutional investors adjusting their positions.
Analysts from HC Wainwright & Co. and D. Boral Capital reiterated buy ratings with targets of $31 and $23.

On June 11, 2026, Mark Mortenson, the Chief Science Officer at CLNN, purchased 45,000 shares of the company. The transaction was recorded at no cost per share, indicating a non-cash arrangement. This move comes as part of a broader insider buying trend within the company.

Other Institutional Activity in CLNN

Several institutional investors have recently adjusted their positions in CLNN. Boxer Capital Management, LLC increased its holdings by 277,778 shares, ending with 477,515 shares valued at about $2.35 million. In contrast, Symbiosis Capital Partners, LLC reduced its stake by 339,401 shares, now holding 431,094 shares worth approximately $2.13 million. Vanguard Capital Management LLC initiated a new position with 308,230 shares valued at roughly $1.52 million. Scoggin Management LP added 25,000 shares, bringing its total to 300,000 shares valued at $1.48 million. Ensign Peak Advisors, Inc also increased its holdings significantly by 143,511 shares, reaching a total of 257,872 shares worth about $1.27 million.

CLNN Stock Snapshot

Shares of CLNN traded at approximately $5.78 recently. The stock has seen several institutional changes, reflecting varied investor sentiment. The stock's performance and insider activity may influence market perceptions moving forward.

Insider Buying and Selling at Clene Inc.

In addition to Mark Mortenson's acquisition, CLNN saw other insiders purchasing shares. On June 11, 2026, Chief Financial Officer Brown Morgan bought 15,000 shares, President & CEO Robert Dee Etherington acquired 65,000 shares, and others made smaller purchases in late May. These transactions were not part of any pre-planned trading programs, suggesting strong insider confidence in the company's future.

Analysts Set New Price Targets

Analysts have shown optimism about CLNN's prospects. On May 4, 2026, HC Wainwright & Co. reiterated a buy rating with a price target of $31. Similarly, D. Boral Capital maintained its buy rating with a $23 target. These positive assessments could influence investor sentiment, supporting potential stock price growth.

Bottom Line

Mark Mortenson's purchase of 45,000 shares of CLNN underscores insider confidence in the company's future. This transaction, alongside other insider buys and institutional activity, suggests varied sentiment in the market. While analysts remain optimistic, with reiterated buy ratings and substantial price targets, investors will watch closely for continued performance and strategic developments.